Relugolix for Injection(Nuoqiao Pharma)

注射用瑞卢戈利(诺桥制药)

Report date: 2025/07/08 16:14:34

Base Information

Drug NameRelugolix for Injection(Nuoqiao Pharma)
Drug Alias NameRelugolixum瑞卢戈利注射用瑞卢戈利(2.2类改良型)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone receptor antagonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A